Medirom Healthcare Technologies Inc Stock Price, News & Analysis

MEDIROM Healthcare Technologies (NASDAQ:MRM) has announced a strategic partnership with Hakuhodo Inc. to join the World Network, a proof of human protocol co-founded by OpenAI creator Sam Altman. The company plans to install "Orb" verification devices in 100 Re.Ra.Ku relaxation salons by December 2025.

The initiative aims to issue 500,000 new World IDs annually, supporting the World protocol's mission to distinguish between humans and AI in the digital age. The World ID system, developed by Tools for Humanity (TFH), uses advanced camera technology to verify human authenticity while maintaining privacy. MEDIROM, which operates over 300 relaxation salons nationwide, will integrate this technology across its Re.Ra.Ku locations as part of the global deployment strategy.

MEDIROM Healthcare Technologies (NASDAQ: MRM) has successfully regained compliance with Nasdaq's minimum bid price requirement. The company, which received a non-compliance notice on February 27, 2025, was required to maintain a minimum closing bid price of $1.00 per share for at least 10 consecutive business days. Nasdaq confirmed that from May 20 to June 3, 2025, MRM's American Depositary Shares consistently met this requirement. The company had been given until August 26, 2025, to resolve the compliance issue, and has now successfully done so ahead of the deadline. With this achievement, Nasdaq has officially closed the matter, confirming MRM's continued listing status.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announces significant milestones for its healthcare app 'Lav', with over 100 contracted companies and 10,000 supported individuals for specific health guidance services. The app, launched in 2019, has facilitated a total weight loss of 15,421 kg among users. Lav serves approximately 1 in 14 health insurance associations in Japan, offering personalized health coaching through chat features, activity tracking, and lifestyle management tools. The app supports Japan's Specific Health Guidance Program, targeting medical insurance subscribers aged 40-74 to prevent lifestyle-related diseases. Users can track weight, steps, sleep, and meals while receiving professional coaching support. The service has received positive evaluations and continues to expand its presence in Japan's healthcare technology sector.

MEDIROM Healthcare Technologies (MRM) reported strong financial results for 2024, with total revenue increasing 22% to $52.7M, up from $43.4M in 2023. Net income improved 20% to $878,000 ($0.17 per share) compared to $731,000 ($0.15 per share) in 2023. The growth was primarily driven by a 23% increase in the Relaxation Salon Segment revenue to $47.3M. The company's cost management improved, with cost of revenues decreasing to 72.9% from 77.0% and SG&A expenses dropping to 27.0% from 28.7%. Cash position strengthened to $2.1M, though total debt increased to $11.9M. In early 2025, MEDIROM completed a $5M ADS offering and secured a $2.4M bank loan. The company aims to expand its Digital Preventative Healthcare business and increase Lav® users through strategic initiatives.

MEDIROM Healthcare Technologies (Nasdaq: MRM) has scheduled a webcast for May 21, 2025, at 8:30 AM ET to discuss its financial results for fiscal year 2024. The company will release its financial results after market close on May 20, 2025. MEDIROM, a Japanese holistic healthcare company, operates 307 relaxation salons under the Re.Ra.Ku® brand and offers various healthcare services. The company has expanded into health tech with its on-demand training app "Lav®", developed the "MOTHER Bracelet®" smart tracker, and launched REMONY, a remote monitoring system for corporate clients. The webcast will be accessible via dial-in numbers for North America, International, and Japan participants, with a replay available until June 4, 2025.

MEDIROM Healthcare Technologies (Nasdaq CM: MRM) has secured a new unsecured short-term bank loan of JPY350 million (approximately $2.4 million) with a 1.875% annual interest rate. JPY200 million of the loan funds will be used to repay the indebtedness of MEDIROM Mother Labs Inc., a subsidiary and loan guarantor.

The remaining funds will support general working capital, including the development of Mother Bracelet. CEO Koji Eguchi stated that this financing strengthens their financial position and provides additional support for the Mother Bracelet development.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs, has made a second investment in Mother Labs' Series A financing. The investment values Mother Labs at a pre-money valuation of JPY9 billion (approximately US$60 million) as of March 13, 2025.

This follow-up investment comes after Mr. Hayami's initial Series A investment in December 2024. As a committed senior executive, Hayami shares MEDIROM's corporate philosophy, vision, and commitment to future growth potential. His background includes founding INIT Co., in 1996, serving as Executive Officer at transcosmos inc. in 2004, and founding Wise, Inc. in 2014. In 2024, he was appointed Chairman of MEDIROM Rehab Solutions and Chief Business Officer of MEDIROM Mother Labs.

MEDIROM Healthcare Technologies (Nasdaq: MRM) released preliminary, unaudited financial results for FY2024 under Japanese GAAP. The company reported total revenue of JPY8.2 billion ($52.6 million), a JPY1.4 billion increase from 2023, driven by salon sales to investors, increased store outsourcing revenue, and revenue from their newly acquired rehabilitation business.

The company's adjusted operating income reached JPY160 million ($1.0 million), marking a significant improvement from the previous year's operating loss. Key performance indicators showed 308 total salons as of December 2024, serving 945,395 customers with an average sales per customer of JPY7,111 ($45.2) and a repeat ratio of 76.3%.

These results exclude approximately JPY140 million in offering-related expenses from their second public equity offering in December 2024. The company notes these preliminary results are subject to final audit under U.S. GAAP standards.

MEDIROM Healthcare Technologies Inc. (MRM) has released its December 2024 Key Performance Indicators. The company reported 80,764 total customers served with sales per customer of JPY 7,384, showing an increase from JPY 7,271 in December 2023. The customer repeat ratio stood at 77.6% with an operation ratio of 45.9%.

The company's salon network comprised 308 locations with 283 providing comparable data. In their Health Tech Business segment featuring the Lav® app, MEDIROM has expanded its presence in the specific health guidance program market, reaching 97 corporate insurance association contracts and 8,816 cumulative users by December 2024.